ReviewFrontiers in immunology2026
Histone lactylation: a metabolic-epigenetic bridge linking glycolysis to salivary gland fibrosis in Sjögren's disease.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sjögren's disease (SjD) is a chronic, systemic autoimmune disorder characterized by lymphocytic infiltration and progressive loss of exocrine gland function. Despite advances in understanding its immunopathogenesis, the molecular mechanisms governing the transition from inflammation to irreversible salivary gland fibrosis remain obscure. Emerging evidence suggests that the crosstalk between metabolic reprogramming and epigenetic modifications profoundly shapes the local inflammatory microenvironment and accelerates disease progression. Histone lactylation, a recently discovered lactate-derived epigenetic mark, directly couples enhanced glycolytic activity and lactate accumulation with transcriptional regulation, thereby serving as a pivotal metabolic-epigenetic bridge. This review systematically examines the potential role of histone lactylation in SjD salivary gland pathology. We delineate the enzymatic machinery of lactylation, the metabolic origins of lactate within the inflamed microenvironment, and the functional implications for immune cell polarization, epithelial-mesenchymal transition, and myofibroblast activation. While direct evidence in SjD is currently lacking, we synthesize findings by integrating immunometabolism, epigenetic rewiring, and tissue fibrogenesis, we aim to establish histone lactylation as a transformative framework for understanding SjD pathogenesis and highlight its translational potential for novel biomarkers and therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.